From: Imagable 4T1 model for the study of late stage breast cancer
WBC Population | Control (n = 1) | Week 1 (n = 3) | Week 4 (n = 4) |
---|---|---|---|
WBC | 5.3002 | 4.200 | 56.210 |
4.200 | 66.000 | ||
2.800 | 15.700 | ||
134.000 | |||
Seg N | 0.424 (8%)3 | 1.386 (33%) | 34.850 (62%) |
0.546 (13%) | 48.840 (74%) | ||
1.148 (41%) | 8.164 (52%) | ||
99.160 (74%) | |||
Band N | - | - | 3.373 (6%) |
- | 3.962 (6%) | ||
- | 0.157 (1%) | ||
10.720 (8%) | |||
Metamyelocytes | - | - | 0.562 (1%) |
- | 0.660 (1%) | ||
- | - | ||
2.680 (2%) | |||
Lymphocytes | 4.823 (91%) | 2.772 (66%) | 16.863 (30%) |
3.654 (87%) | 10.560 (16%) | ||
1.624 (58%) | 6.594 (42%) | ||
20.100 (15%) | |||
Monocytes | - | - | - |
- | 1.320 (2%) | ||
- | 0.314 (2%) | ||
- | |||
Eosinophils | 0.053 (1%) | 0.042 (1%) | 0.562 (1%) |
- | 0.660 (1%) | ||
0.028 (1%) | 0.471 (3%) | ||
1.340 (1%) |